-
All Events
ProMED and COVID-19 - A Q&A With Our Moderator Team19th ICID Research Posters -
All Content TypesAbstractAccredited ActivityAccredited CourseArticle ReviewAudio PodcastCase StudyClinical CaseCurriculumDocumente-BookePosterExternal LectureExternal ViewerIndexed SlideJournal ArticleLearning QuizLive StreamMatching SlidePodcastPPT SharedSelf-Test CaseSession HighlightTechnical VideoVideo SessionWebcast
-
Sort ByRelevance
-
All TopicsAll Topics
Protected by US Patents
About this activity
Discussion Forum (0)
Treatment Strategies for Dengue Infection
This webinar is Open-Access (no login required) and was hosted on Tuesday, July 25, 2023, from 8:00 - 9:00 am EDT. (5:30/PM Sri Lanka, 8:00PM/Singapore).
If you are unable to attend the live event, bookmark this link! An on-demand version will be available after the webinar’s conclusion, and a post-produced version (with slide navigation) within a few hours.
Chair: Neelika Malavige, Sri Lanka
Co-Chair: Muhammed Niyas, India
Speakers:
Webinar Outline:
Dengue is a public health problem that continues to increase globally. Dengue is spreading to new areas, including Europe, with some countries reporting first-time local transmission cases. As treatment options are limited, public health control measures include strengthening national programs to meet objectives through coordinated efforts inside and outside the health sector. There is currently no definitive treatment for dengue; only supportive treatment is available for patients with the infection.
However, there have been recent advances in the development of promising drugs for dengue therapeutics, including direct antivirals and host-targeted drugs for reducing inflammation and vascular pathologies. Developing novel vector control methods and new approaches to case management are important for prevention and control. A safe and efficacious vaccine remains the foundation of a comprehensive countermeasure strategy. Recent advances in host-targeted pathways and novel therapeutic approaches are crucial and should be integrated into the research agenda with current vector control tools and vaccination developments.
This webinar is supported by an unrestricted educational grant from Takeda.
Please take 2 minutes after the webinar to fill out our evaluation form: https://isid.typeform.com/to/uysKykCD
This webinar is Open-Access (no login required) and was hosted on Tuesday, July 25, 2023, from 8:00 - 9:00 am EDT. (5:30/PM Sri Lanka, 8:00PM/Singapore).
If you are unable to attend the live event, bookmark this link! An on-demand version will be available after the webinar’s conclusion, and a post-produced version (with slide navigation) within a few hours.
Chair: Neelika Malavige, Sri Lanka
Co-Chair: Muhammed Niyas, India
Speakers:
- Targeting Host Pathways for Dengue Treatment - Ashley St. John, Singapore
- Anti-Dengue Drug Development - Eng Eong Ooi, Singapore
Webinar Outline:
Dengue is a public health problem that continues to increase globally. Dengue is spreading to new areas, including Europe, with some countries reporting first-time local transmission cases. As treatment options are limited, public health control measures include strengthening national programs to meet objectives through coordinated efforts inside and outside the health sector. There is currently no definitive treatment for dengue; only supportive treatment is available for patients with the infection.
However, there have been recent advances in the development of promising drugs for dengue therapeutics, including direct antivirals and host-targeted drugs for reducing inflammation and vascular pathologies. Developing novel vector control methods and new approaches to case management are important for prevention and control. A safe and efficacious vaccine remains the foundation of a comprehensive countermeasure strategy. Recent advances in host-targeted pathways and novel therapeutic approaches are crucial and should be integrated into the research agenda with current vector control tools and vaccination developments.
This webinar is supported by an unrestricted educational grant from Takeda.
Please take 2 minutes after the webinar to fill out our evaluation form: https://isid.typeform.com/to/uysKykCD
Treatment Strategies for Dengue Infection
Neelika Malavige
Muhammed Niyas
Ashley St John
Eng Eong Ooi
Affiliations:
Duke-NUS Medical School
Duke-NUS Medical School
About this activity
Discussion Forum (0)
Treatment Strategies for Dengue Infection
This webinar is Open-Access (no login required) and was hosted on Tuesday, July 25, 2023, from 8:00 - 9:00 am EDT. (5:30/PM Sri Lanka, 8:00PM/Singapore).
If you are unable to attend the live event, bookmark this link! An on-demand version will be available after the webinar’s conclusion, and a post-produced version (with slide navigation) within a few hours.
Chair: Neelika Malavige, Sri Lanka
Co-Chair: Muhammed Niyas, India
Speakers:
Webinar Outline:
Dengue is a public health problem that continues to increase globally. Dengue is spreading to new areas, including Europe, with some countries reporting first-time local transmission cases. As treatment options are limited, public health control measures include strengthening national programs to meet objectives through coordinated efforts inside and outside the health sector. There is currently no definitive treatment for dengue; only supportive treatment is available for patients with the infection.
However, there have been recent advances in the development of promising drugs for dengue therapeutics, including direct antivirals and host-targeted drugs for reducing inflammation and vascular pathologies. Developing novel vector control methods and new approaches to case management are important for prevention and control. A safe and efficacious vaccine remains the foundation of a comprehensive countermeasure strategy. Recent advances in host-targeted pathways and novel therapeutic approaches are crucial and should be integrated into the research agenda with current vector control tools and vaccination developments.
This webinar is supported by an unrestricted educational grant from Takeda.
Please take 2 minutes after the webinar to fill out our evaluation form: https://isid.typeform.com/to/uysKykCD
This webinar is Open-Access (no login required) and was hosted on Tuesday, July 25, 2023, from 8:00 - 9:00 am EDT. (5:30/PM Sri Lanka, 8:00PM/Singapore).
If you are unable to attend the live event, bookmark this link! An on-demand version will be available after the webinar’s conclusion, and a post-produced version (with slide navigation) within a few hours.
Chair: Neelika Malavige, Sri Lanka
Co-Chair: Muhammed Niyas, India
Speakers:
- Targeting Host Pathways for Dengue Treatment - Ashley St. John, Singapore
- Anti-Dengue Drug Development - Eng Eong Ooi, Singapore
Webinar Outline:
Dengue is a public health problem that continues to increase globally. Dengue is spreading to new areas, including Europe, with some countries reporting first-time local transmission cases. As treatment options are limited, public health control measures include strengthening national programs to meet objectives through coordinated efforts inside and outside the health sector. There is currently no definitive treatment for dengue; only supportive treatment is available for patients with the infection.
However, there have been recent advances in the development of promising drugs for dengue therapeutics, including direct antivirals and host-targeted drugs for reducing inflammation and vascular pathologies. Developing novel vector control methods and new approaches to case management are important for prevention and control. A safe and efficacious vaccine remains the foundation of a comprehensive countermeasure strategy. Recent advances in host-targeted pathways and novel therapeutic approaches are crucial and should be integrated into the research agenda with current vector control tools and vaccination developments.
This webinar is supported by an unrestricted educational grant from Takeda.
Please take 2 minutes after the webinar to fill out our evaluation form: https://isid.typeform.com/to/uysKykCD
{{ help_message }}
{{filter}}